Regulation of KHNYN antiviral activity by the extended di-KH domain and nucleo-cytoplasmic trafficking
M. J. Lista, R. P. Galao, M. Ficarelli, D. Kmiec, H. Wilson, H. Winstone, E. R. Morris, H. E. Mischo, J. Wanford, R. Youle, C. Odendall, I. A. Taylor, S. J. Neil, C. Swanson
Abstract
The zinc finger antiviral protein (ZAP) restricts a broad range of viruses by binding CpG dinucleotides in viral RNA to target it for degradation and inhibit its translation. KHNYN was recently identified as an antiviral protein required for ZAP to inhibit retroviral replication, though little is known about its functional determinants. KHNYN contains an N-terminal extended di-KH-like domain, a PIN endoribonuclease domain and a C-terminal CUBAN domain that binds NEDD8 and ubiquitin. We show that deletion of the extended di-KH domain reduces its antiviral activity. However, despite its similarity to RNA binding KH domains, the extended di-KH domain in KHNYN does not appear to bind RNA. Mutation of residues in the CUBAN domain that bind NEDD8 increase KHNYN abundance but do not alter its antiviral activity, suggesting that this interaction regulates KHNYN homeostatic turnover. In contrast, a CRM1-dependent nuclear export signal (NES) at the C-terminus of the CUBAN domain is required for antiviral activity. Deletion of this signal retains KHNYN in the nucleus and inhibits its interaction with ZAP. Interestingly, this NES appeared in the KHNYN lineage at a similar time as when ZAP evolved in tetrapods, indicating that these proteins may have co-evolved to restrict viral replication. AUTHOR SUMMARYAntiviral proteins restrict viral replication in many different ways, including inhibiting viral gene expression. ZAP is an antiviral RNA binding protein that must interact with other cellular proteins to inhibit viral protein synthesis. KHNYN is a ZAP cofactor that is required for it to inhibit retroviral replication. Because little is known about how KHNYN functions in this role, we have analyzed how two of its domains regulate its antiviral activity. We first show that the extended di-KH domain in KHNYN is required for its antiviral activity. While it is related to di-KH domains in RNA binding proteins, it appears to have lost its ability to bind RNA and KHNYN likely acts in the restriction pathway after ZAP binds a target viral RNA. Second, we show that the KHNYN CUBAN domain regulates both its protein abundance and trafficking within the cell. The CUBAN domain contains a nuclear export signal and, when this signal is mutated, KHNYN is sequestered in the nucleus, has substantially reduced antiviral activity and does not interact with ZAP. Overall, we show that the extended di-KH and CUBAN domains in KHNYN are required for it to act as a cofactor for ZAP to restrict viral replication.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A nuclear export signal in KHNYN required for its antiviral activity evolved as ZAP emerged in tetrapods
M. J. Lista, M. Ficarelli, … C. M. Swanson·bioRxiv·May 31, 2022
- Structural and functional characterization of the KHNYN extended-diKH domain for mediating ZAP antiviral activity
Rebecca L Youle, María José Lista, … Chad M. Swanson·Journal of Biological ChemistryPeer-reviewed·Feb 19, 2025
- KHNYN is essential for ZAP-mediated restriction of HIV-1 containing clustered CpG dinucleotides
M. Ficarelli, H. Wilson, … C. M. Swanson·bioRxiv·Mar 18, 2019
- The C-terminal PARP domain of the long ZAP isoform contributes essential effector functions for CpG-directed antiviral activity
D. Kmiec, M. J. Lista, … S. J. D. Neil·bioRxiv·Jun 22, 2021
- The long isoform of ZAP coordinates multiple enzymes to mediate complete decay of target transcripts
Clément R. Bouton, Grega Gimpelj Domjanič, … Chad M. Swanson·Cell ReportsPeer-reviewed·May 1, 2026
- Decreasing ZAP Poly(ADP-ribose) Binding Enhances Antiviral Activity Against Alphaviruses
Shang-Jung Cheng, Diane E. Griffin, … Rachy Abraham·bioRxiv·Aug 30, 2024